Adipocytokines and disease progression in endometrial cancer: a systematic review
- PMID: 34951691
- PMCID: PMC8924097
- DOI: 10.1007/s10555-021-10002-6
Adipocytokines and disease progression in endometrial cancer: a systematic review
Erratum in
-
Correction to: Adipocytokines and disease progression in endometrial cancer: a systematic review.Cancer Metastasis Rev. 2024 Jun;43(2):849-863. doi: 10.1007/s10555-022-10020-y. Cancer Metastasis Rev. 2024. PMID: 35084608 Free PMC article. No abstract available.
Abstract
The objective of the study was to document the effect of adipocytokines on endometrial cancer progression. A search of the databases CINAHL, Medline, PubMed, Cochrane, Web of Science, Embase and Google Scholar was performed for English language articles from January 2000 to December 2020 using the keywords: (Endometrial cancer) AND (progression OR metastasis) AND (adipocytokine OR adiponectin OR leptin OR visfatin OR IL-6 OR TNF-α OR adipokine OR cytokine). Forty-nine studies on adipocytokines have been included in this review. Adiponectin has been linked with anti-proliferative and anti-metastatic effects on endometrial cancer cells and is associated with a better prognosis. Leptin, visfatin and resistin are linked to the stimulation of endometrial cancer growth, proliferation, invasion and metastasis and are associated with worse prognosis or with a higher grade/stage of endometrial cancer. IL-6, Il-11, IL-31, IL-33, TNF-α, TGF-β1, SDF-1 and CXCR are involved in endometrial cancer cell growth and metastasis or involved in epithelial mesenchymal transformation (EMT) or associated with advanced disease. Adipocytokines have been found to directly impact endometrial cancer cell proliferation, invasion and migration. These molecules and their signalling pathways may be used to determine prognosis and course of the disease and may also be exploited as potential targets for cancer treatment and prevention of progression.
Keywords: Adipocytokines; Adipokines; Cytokines; Disease progression; Endometrial cancer; Systematic review.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Dimitrov T, Gorchev G, Tomov S. Modern concepts of ethiological pathogenesis and treatment of endometrial carcinoma, research literature review. International Journal of Science and Research (IJSR) 2016;5(7):440–445. doi: 10.21275/v5i7.ART2016122. - DOI
-
- Uterine cancer incidence statistics. Cancer Research UK. Accessed Oct 2020, from http://www.cancerresearchuk.org/health-professional/cancer-statistics/st....
-
- Cancer facts and figures 2021. American Cancer Society. Accessed May 2021 from https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts...
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Erratum in: CA Cancer J Clin. 2020;70(4):313. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources